UniTartu Ventures

UniTartu Ventures is the investment arm of the University of Tartu, established to direct the university's intellectual property into research- and technology-intensive companies. The firm collaborates with early-stage deep tech investors, researchers, startups, and spin-offs associated with the university, aiming to transform academic research into thriving businesses. Through an 'IP-for-equity' model, UniTartu Ventures provides mentorship, assists in intellectual property strategies, prepares startups for investment, and attracts co-investors to support innovative ideas.

The company's investment focus spans various sectors, including life sciences, processing and computing, food tech, agritech, energy, cleantech, and infrastructure. By investing in university research, UniTartu Ventures not only supports the commercialization of academic knowledge but also contributes to the development of Estonia's smart economy. The firm has been involved in several notable investments, such as Vectiopep OÜ, a health technology company developing novel immunotherapy-based cancer treatments. This investment underscores UniTartu Ventures' commitment to advancing research-based entrepreneurship and fostering innovation within the university's ecosystem.

UniTartu Ventures operates with a dedicated team, including Investment Director Mart Maasik, who brings extensive experience in innovation management and business development. The firm's approach combines strategic coordination at the university level with the flexibility of the entrepreneurial environment, facilitating the creation and growth of research-oriented startups. This model exemplifies how a university can systematically manage its commercialization activities, invest in spin-offs, and motivate researchers to engage in entrepreneurship, thereby strengthening the link between Estonia's economy and science.